About ginkgo bioworks holdings inc - DNA
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
DNA At a Glance
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
Boston, Massachusetts 02210
| Phone | 1-877-422-5362 | Revenue | 227.04M | |
| Industry | Medical/Nursing Services | Net Income | -547,029,000.00 | |
| Sector | Health Services | Employees | 834 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
DNA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.245 |
| Price to Book Ratio | 0.704 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.032 |
| Enterprise Value to Sales | 1.805 |
| Total Debt to Enterprise Value | 1.141 |
DNA Efficiency
| Revenue/Employee | 272,233.813 |
| Income Per Employee | -655,910.072 |
| Receivables Turnover | 10.116 |
| Total Asset Turnover | 0.149 |
DNA Liquidity
| Current Ratio | 5.619 |
| Quick Ratio | 5.619 |
| Cash Ratio | 5.29 |
DNA Profitability
| Gross Margin | 60.55 |
| Operating Margin | -202.737 |
| Pretax Margin | -241.147 |
| Net Margin | -240.936 |
| Return on Assets | -35.956 |
| Return on Equity | -60.338 |
| Return on Total Capital | -46.21 |
| Return on Invested Capital | -44.226 |
DNA Capital Structure
| Total Debt to Total Equity | 65.32 |
| Total Debt to Total Capital | 39.511 |
| Total Debt to Total Assets | 33.956 |
| Long-Term Debt to Equity | 61.275 |
| Long-Term Debt to Total Capital | 37.065 |